Novel Immune Targets in Melanoma—Response.
Full text not available from this repository.| Item Type: | Article |
|---|---|
| Status: | Published |
| Official URL: | https://doi.org/10.1158/1078-0432.CCR-19-1866 |
| Journal or Publication Title: | Clinical Cancer Research |
| Volume: | 25 |
| Number: | 17 |
| Page Range: | pp. 5424-5425 |
| Date: | 2019 |
| Divisions: | Human Viral and Cancer Immunology |
| Depositing User: | General Admin |
| Identification Number: | 10.1158/1078-0432.CCR-19-1866 |
| ISSN: | 1078-0432 |
| Date Deposited: | 21 Dec 2020 05:47 |
| Abstract: | No abstract available. Editorial comment on: Prevalence and Cellular Distribution of Novel Immune Checkpoint Targets Across Longitudinal Specimens in Treatment-naïve Melanoma Patients: Implications for Clinical Trials. Tasker et al Clin Cancer Res. 2019 Jun 1;25(11):3247-3258. doi: 10.1158/1078-0432.CCR-18-4011. |
| Creators: | Creators Email Edwards, Jarem UNSPECIFIED Batten, Marcel UNSPECIFIED Ferguson, Angela UNSPECIFIED Palendira, Umaimainthan UNSPECIFIED Wilmott, James S. UNSPECIFIED Long, Georgina V. UNSPECIFIED Scolyer, Richard A. UNSPECIFIED |
| Last Modified: | 21 Dec 2020 05:47 |
| URI: | https://eprints.centenary.org.au/id/eprint/355 |
Actions (login required)
 |
View Item |
